Literature DB >> 22475858

Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review.

E Jauneikaite1, J M Jefferies, M L Hibberd, S C Clarke.   

Abstract

BACKGROUND: Streptococcus pneumoniae is a major cause of bacterial infections resulting in significant morbidity and mortality worldwide. Currently, up to 13 serotypes are included in pneumococcal conjugate vaccines (PCVs). However, the serotype formulation of these vaccines was initially designed to protect children against serotypes most commonly causing invasive disease in North America, and may not reflect the serotype distribution across the world. Data regarding pneumococcal epidemiology from the other parts of the world, in particular South East Asia, has not been reviewed.
METHODS: This systematic literature review analyses published serotype data regarding S. pneumoniae isolates from South East Asian countries (defined as countries belonging to the Association of South East Asian Nations, ASEAN): Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand and Vietnam up to 3rd of March 2012.
RESULTS: Analysis of data from six ASEAN countries, from which information on pneumococcal serotypes was available, showed that the most common disease causing serotypes (in rank order) were 19F, 23F, 14, 6B, 1, 19A and 3. Serotype distribution of pneumococcal isolates was similar across the ASEAN region. Serotype level data was more commonly reported for pneumococcal isolates causing invasive pneumococcal disease than for those from non-invasive disease. Studies from Malaysia, Thailand and Singapore contributed the largest proportion of pneumococcal isolates, and serotype data, when compared to other ASEAN countries.
CONCLUSION: This review demonstrates that the majority of IPD causing serotypes in SE Asia are included in currently licensed PCVs. However, PCV's are included in the routine childhood immunisation schedule of only one of the ten countries included in this analysis. Our findings demonstrate the scarcity of information available on serotype prevalence and distribution of pneumococci in SE Asia.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22475858     DOI: 10.1016/j.vaccine.2012.03.066

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  36 in total

1.  Molecular detection and genotypic characterisation of Streptococcus pneumoniae isolated from children in Malaysia.

Authors:  Shu Ling Goh; Boon Pin Kee; Kartini Abdul Jabar; Kek Heng Chua; Anna Marie Nathan; Jessie Bruyne; Soo Tein Ngoi; Cindy Shuan Ju Teh
Journal:  Pathog Glob Health       Date:  2020-01-31       Impact factor: 2.894

2.  Invasive and noninvasive Streptococcus pneumoniae capsule and surface protein diversity following the use of a conjugate vaccine.

Authors:  Christina M Croney; Moon H Nahm; Steven K Juhn; David E Briles; Marilyn J Crain
Journal:  Clin Vaccine Immunol       Date:  2013-09-04

3.  Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012.

Authors:  Wanatpreeya Phongsamart; Somporn Srifeungfung; Tanittha Chatsuwan; Pongpun Nunthapisud; Vipa Treerauthaweeraphong; Pimpha Rungnobhakhun; Sirintip Sricharoenchai; Kulkanya Chokephaibulkit
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Mucosal immunization with recombinant fusion protein DnaJ-ΔA146Ply enhances cross-protective immunity against Streptococcus pneumoniae infection in mice via interleukin 17A.

Authors:  Yusi Liu; Hong Wang; Shuai Zhang; Lingbin Zeng; Xiuyu Xu; Kaifeng Wu; Wei Wang; Nanlin Yin; Zhixin Song; Xuemei Zhang; Yibing Yin
Journal:  Infect Immun       Date:  2014-02-03       Impact factor: 3.441

5.  Cost-effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong.

Authors:  David Bin-Chia Wu; Craig Roberts; Vivian Wing Yan Lee; Li-Wen Hong; Kah Kee Tan; Vivienne Mak; Kenneth Kwing Chin Lee
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

6.  Serotype distribution and antibiotic susceptibility of invasive Streptococcus pneumoniae isolates in patients aged 50 years or older in Thailand.

Authors:  Somporn Srifeungfung; Wanatpreeya Phongsamart; Chanwit Tribuddharat; Tanittha Chatsuwan; Pimpha Rungnobhakhun; Suwandee Sapcharoen; Kulkanya Chokephaibulkit
Journal:  Hum Vaccin Immunother       Date:  2013-09-12       Impact factor: 3.452

7.  Dynamics of serotype 14 Streptococcus pneumoniae population causing acute respiratory infections among children in China (1997-2012).

Authors:  Mingming He; Kaihu Yao; Wei Shi; Wei Gao; Lin Yuan; Sangjie Yu; Yonghong Yang
Journal:  BMC Infect Dis       Date:  2015-07-11       Impact factor: 3.090

8.  Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae.

Authors:  Hassan Mahmood Jindal; Cheng Foh Le; Mohd Yasim Mohd Yusof; Rukumani Devi Velayuthan; Vannajan Sanghiran Lee; Sharifuddin Md Zain; Diyana Mohd Isa; Shamala Devi Sekaran
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

Review 9.  Penicillin-Resistant trend of Streptococcus pneumoniae in Asia: A systematic review.

Authors:  Setareh Mamishi; Sepideh Moradkhani; Shima Mahmoudi; Reihaneh Hosseinpour-Sadeghi; Babak Pourakbari
Journal:  Iran J Microbiol       Date:  2014-08

10.  Serotypes and patterns of antibiotic resistance in strains causing invasive pneumococcal disease in children less than 5 years of age.

Authors:  Chunfeng Liu; Xiaoyu Xiong; Wei Xu; Jimei Sun; Lijie Wang; Jiujun Li
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.